Weiliang Lu

675 total citations
13 papers, 402 citations indexed

About

Weiliang Lu is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Weiliang Lu has authored 13 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Cancer Research and 3 papers in Genetics. Recurrent topics in Weiliang Lu's work include RNA modifications and cancer (3 papers), Renal cell carcinoma treatment (2 papers) and Prenatal Screening and Diagnostics (2 papers). Weiliang Lu is often cited by papers focused on RNA modifications and cancer (3 papers), Renal cell carcinoma treatment (2 papers) and Prenatal Screening and Diagnostics (2 papers). Weiliang Lu collaborates with scholars based in China, United States and Canada. Weiliang Lu's co-authors include Shufang Liang, Ningzhi Xu, Jingjing Liu, Zijing Xia, E. Lee, Bing Chen, Yuling Liu, Xia Zhao, Qiong Yuan and Dan Zhang and has published in prestigious journals such as PLoS ONE, Cancer Letters and Cell Death and Disease.

In The Last Decade

Weiliang Lu

13 papers receiving 396 citations

Peers

Weiliang Lu
Nana Lee United States
Xingru Li China
Gholamreza Rafiee United Kingdom
Nana Lee United States
Weiliang Lu
Citations per year, relative to Weiliang Lu Weiliang Lu (= 1×) peers Nana Lee

Countries citing papers authored by Weiliang Lu

Since Specialization
Citations

This map shows the geographic impact of Weiliang Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiliang Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiliang Lu more than expected).

Fields of papers citing papers by Weiliang Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiliang Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiliang Lu. The network helps show where Weiliang Lu may publish in the future.

Co-authorship network of co-authors of Weiliang Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Weiliang Lu. A scholar is included among the top collaborators of Weiliang Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiliang Lu. Weiliang Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
He, Yu, Xixi Wang, Weiliang Lu, et al.. (2022). PGK1 contributes to tumorigenesis and sorafenib resistance of renal clear cell carcinoma via activating CXCR4/ERK signaling pathway and accelerating glycolysis. Cell Death and Disease. 13(2). 118–118. 53 indexed citations
2.
Su, Jiasun, Weiliang Lu, Mengting Li, et al.. (2021). Novel compound heterozygous frameshift variants in WDR81 associated with congenital hydrocephalus 3 with brain anomalies: First Chinese prenatal case confirms WDR81 involvement. Molecular Genetics & Genomic Medicine. 9(4). e1624–e1624. 3 indexed citations
3.
Su, Jiasun, Zailong Qin, Jingsi Luo, et al.. (2021). Association of prenatal renal ultrasound abnormalities with pathogenic copy number variants in a large Chinese cohort. Ultrasound in Obstetrics and Gynecology. 59(2). 226–233. 21 indexed citations
4.
Yu, Yang, Qinglv Wei, Yuling Tang, et al.. (2020). Loss of hnRNPA2B1 inhibits malignant capability and promotes apoptosis via down-regulating Lin28B expression in ovarian cancer. Cancer Letters. 475. 43–52. 54 indexed citations
5.
Qin, Zailong, Jiasun Su, Mengting Li, et al.. (2020). Clinical and Genetic Analysis of CHD7 Expands the Genotype and Phenotype of CHARGE Syndrome. Frontiers in Genetics. 11. 592–592. 9 indexed citations
6.
Lu, Weiliang, Ming‐Xing Liang, Jiasun Su, et al.. (2020). Novel compound heterozygous pathogenic variants in ASCC1 in a Chinese patient with spinal muscular atrophy with congenital bone fractures 2 : Evidence supporting a "Definitive" gene‐disease relationship. Molecular Genetics & Genomic Medicine. 8(5). e1212–e1212. 6 indexed citations
7.
Su, Jiasun, Bobo Xie, Weiliang Lu, et al.. (2019). Prenatal diagnosis of cri-du-chat syndrome by SNP array: report of twelve cases and review of the literature. Molecular Cytogenetics. 12(1). 7 indexed citations
8.
Zhang, Dan, Xixi Wang, Peng Zhang, et al.. (2017). PGRMC1 Is a Novel Potential Tumor Biomarker of Human Renal Cell Carcinoma Based on Quantitative Proteomic and Integrative Biological Assessments. PLoS ONE. 12(1). e0170453–e0170453. 26 indexed citations
9.
Lu, Weiliang, Xixi Wang, Jingjing Liu, et al.. (2016). Downregulation of ARHGDIA contributes to human glioma progression through activation of Rho GTPase signaling pathway. Tumor Biology. 37(12). 15783–15793. 14 indexed citations
10.
Liu, Yuling, Jingjing Liu, Weiliang Lu, et al.. (2015). The Overexpression of IQGAP1 and β-Catenin Is Associated with Tumor Progression in Hepatocellular Carcinoma In Vitro and In Vivo. PLoS ONE. 10(8). e0133770–e0133770. 30 indexed citations
11.
Chen, Bing, Yuling Liu, Weiliang Lu, et al.. (2014). MicroRNA-26a regulates glucose metabolism by direct targeting PDHX in colorectal cancer cells. BMC Cancer. 14(1). 443–443. 103 indexed citations
12.
Lu, Weiliang, et al.. (1987). Balanced approximation of two-dimensional and delay-differential systems. International Journal of Control. 46(6). 2199–2218. 42 indexed citations
13.
Lu, Weiliang, et al.. (1986). Balanced approximation of two-dimensional and delay-differential systems. 917–922. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026